Denali Therapeutics Inc.
DNLI
Revenue
0.00
0.000.00%
3 Months ChangeAssets
1.37B
▼-79.83M▼-5.49%
3 Months ChangeLiabilities
144.50M
▲8.98M▲6.62%
3 Months ChangeFree Cash Flow
-115.77M
▼-54.18M▼-87.97%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-10
Form 8-K
ID: 0001714899-24-000205
2024-08-01
Form 10-Q
ID: 0001714899-24-000169
2024-08-01
Form 8-K
ID: 0001714899-24-000168
2024-05-31
Form 8-K
ID: 0001714899-24-000125
2024-05-07
Form 10-Q
ID: 0001714899-24-000121
2024-05-07
Form 8-K
ID: 0001714899-24-000120
2024-02-27
Form 8-K
ID: 0001714899-24-000076
2024-02-27
Form 8-K
ID: 0001714899-24-000075
2024-02-16
Form 8-K
ID: 0001714899-24-000065
2024-01-08
Form 8-K
ID: 0001714899-24-000031